Literature DB >> 16050250

Multipotent adult progenitor cells: an update.

Catherine M Verfaillie1.   

Abstract

The quintessential stem cell is the embryonal stem (ES) cell which has unlimited self-renewal and multipotent differentiation potential. Stem cells have also been identified in most tissues. Compared with ES cells, tissue-specific stem cells have less self-renewal ability and, although they differentiate into multiple lineages, they are not multipotent. A large number of recent published studies have suggested that tissue-specific stem cells may have the ability to generate cells of tissues from unrelated organs. We have identified a population of primitive cells in normal human, rodent, and possibly other mammalian postnatal tissues that have, at the single cell level, multipotent differentiation and extensive proliferation potential, which we named multipotent adult progenitor cell (MAPC). We will discuss studies aimed at determining whether MAPCs also exist in bone marrow of other species, whether MAPCs exist in vivo or are a culture phenomenon, to further characterize MAPCs using gene expression profiling, and effects of in vivo transplantation of MAPCs.

Entities:  

Mesh:

Year:  2005        PMID: 16050250

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  9 in total

1.  Adult murine bone marrow-derived very small embryonic-like stem cells differentiate into the hematopoietic lineage after coculture over OP9 stromal cells.

Authors:  Janina Ratajczak; Marcin Wysoczynski; Ewa Zuba-Surma; Wu Wan; Magda Kucia; Mervin C Yoder; Mariusz Z Ratajczak
Journal:  Exp Hematol       Date:  2010-10-27       Impact factor: 3.084

2.  Hypoxic adipocytes pattern early heterotopic bone formation.

Authors:  Elizabeth Olmsted-Davis; Francis H Gannon; Mustafa Ozen; Michael M Ittmann; Zbigniew Gugala; John A Hipp; Kevin M Moran; Christine M Fouletier-Dilling; Shannon Schumara-Martin; Ronald W Lindsey; Michael H Heggeness; Malcolm K Brenner; Alan R Davis
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 3.  Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis.

Authors:  Maria Grazia Perino; Satoshi Yamanaka; Jinliang Li; Anna M Wobus; Kenneth R Boheler
Journal:  J Mol Cell Cardiol       Date:  2008-05-11       Impact factor: 5.000

4.  A novel role for proteomics in the discovery of cell-surface markers on stem cells: Scratching the surface.

Authors:  Rebekah L Gundry; Kenneth R Boheler; Jennifer E Van Eyk; Bernd Wollscheid
Journal:  Proteomics Clin Appl       Date:  2008-06-12       Impact factor: 3.494

5.  Adult bone marrow neural crest stem cells and mesenchymal stem cells are not able to replace lost neurons in acute MPTP-lesioned mice.

Authors:  Virginie Neirinckx; Alice Marquet; Cécile Coste; Bernard Rogister; Sabine Wislet-Gendebien
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

6.  Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway.

Authors:  Kenichi Tamama; Chandan K Sen; Alan Wells
Journal:  Stem Cells Dev       Date:  2008-10       Impact factor: 3.272

Review 7.  Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation.

Authors:  Peter A Walker; Shinil K Shah; Matthew T Harting; Charles S Cox
Journal:  Dis Model Mech       Date:  2009 Jan-Feb       Impact factor: 5.758

Review 8.  Mesenchymal stem cells and cardiac repair.

Authors:  Catharina Nesselmann; Nan Ma; Karen Bieback; Wolfgang Wagner; Anthony Ho; Yrjö T Konttinen; Hao Zhang; Mihail E Hinescu; Gustav Steinhoff
Journal:  J Cell Mol Med       Date:  2008-08-05       Impact factor: 5.310

Review 9.  The immune boundaries for stem cell based therapies: problems and prospective solutions.

Authors:  Abdelkrim Hmadcha; Hmadcha Abdelkrim; Juan Domínguez-Bendala; Domínguez-Bendala Juan; Jane Wakeman; Wakeman Jane; Mohamed Arredouani; Arredouani Mohamed; Bernat Soria; Soria Bernat
Journal:  J Cell Mol Med       Date:  2009-07-06       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.